Radiopharm Theranostics (RADX) Stock Price, Quote, News & History

Radiopharm Theranostics Ltd (RADX) Stock Price, Quote, News & History

RADXNASDAQ

Trade with Public

$4.40

0.081.85%

At close: Apr 2, 5:00 PM EST

$4.12

-0.28-6.25%

After Hours: 4:38 PM EST

Key Statistics

Open

$4.19

$4.40

Volume / Avg.

23.97K / 164.80K

Day Range

$4.16 - $4.40

52 Wk Range

3.50 - 16.25

Market Cap

$32.09M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.51%

Days to Cover

Recent Radiopharm Theranostics Ltd News

Radiopharm Theranostics Eyes Pivotal Trial Path After Encouraging Interim Results

Radiopharm Theranostics says Phase 2b interim data showing 90% MRI concordance for RAD 101, with final readout expected by June.

Vandana Singh

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics shares rise after interim Phase 2b data showed 92% MRI concordance for RAD 101 imaging in brain metastases.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

1.77M

Financing Cash Flow (TTM)

45.43M

Free Cash Flow (TTM)

-36.65M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

10.56M

Analyst Trends and Forecast

Nov 25

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$14.06M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

13.69

PB Ratio (TTM)

1.11

Earnings Yield % (TTM)

-84.58%

Earnings Yield % (FWD)

-48.68%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$3.93

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$1.90M

Total Cash

$36.44M

Debt to Equity

Issuance of Debt (TTM)

-$1.90M

Repayment of Debt (TTM)

-$1.90M

Key Statistics

Open

$4.19

$4.40

Volume / Avg.

23.97K / 164.80K

Day Range

$4.16 - $4.40

52 Wk Range

3.50 - 16.25

Market Cap

$32.09M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.51%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pr...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Radiopharm Theranostics (RADX) stock?

You can purchase shares of Radiopharm Theranostics (NASDAQ:RADX) through any online brokerage.

View our list of the best stock brokerages

Who are Radiopharm Theranostics (RADX) competitors?

Other companies in Radiopharm Theranostics’s space includes: Kyntra Bio Inc (NASDAQ:KYNB), Evaxion AS (NASDAQ:EVAX), Atossa Therapeutics Inc (NASDAQ:ATOS), Sensei Biotherapeutics Inc (NASDAQ:SNSE) and Palatin Technologies Inc (AMEX:PTN).

What is the forecast, or price target, for Radiopharm Theranostics (RADX) stock?

Radiopharm Theranostics has a consensus price target of $15.33.

What is the current price for Radiopharm Theranostics (RADX)?

The stock price for Radiopharm Theranostics (NASDAQ: RADX) is $4.1248 last updated April 2, 2026 at 4:38 PM EDT.

Does Radiopharm Theranostics (RADX) pay a dividend?

There are no upcoming dividends for Radiopharm Theranostics.

When is Radiopharm Theranostics (NASDAQ:RADX) reporting earnings?

Radiopharm Theranostics does not have any upcoming earnings scheduled.

Is Radiopharm Theranostics (RADX) going to split?

There is no upcoming split for Radiopharm Theranostics.

What sector and industry does Radiopharm Theranostics (RADX) operate in?

Radiopharm Theranostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Atossa Therapeutics Inc

NASDAQ:ATOS

$5.56

3.51%

Sensei Biotherapeutics Inc

PTN

Key Statistics

Open

$4.19

$4.40

Volume / Avg.

23.97K / 164.80K

Day Range

$4.16 - $4.40

52 Wk Range

3.50 - 16.25

Market Cap

$32.09M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.51%

Days to Cover

Recent Radiopharm Theranostics Ltd News

Radiopharm Theranostics Eyes Pivotal Trial Path After Encouraging Interim Results

Radiopharm Theranostics says Phase 2b interim data showing 90% MRI concordance for RAD 101, with final readout expected by June.

Vandana Singh

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics shares rise after interim Phase 2b data showed 92% MRI concordance for RAD 101 imaging in brain metastases.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

1.77M

Financing Cash Flow (TTM)

45.43M

Free Cash Flow (TTM)

-36.65M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

10.56M

Analyst Trends and Forecast

Nov 25

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$14.06M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

13.69

PB Ratio (TTM)

1.11

Earnings Yield % (TTM)

-84.58%

Earnings Yield % (FWD)

-48.68%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$3.93

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$1.90M

Total Cash

$36.44M

Debt to Equity

Issuance of Debt (TTM)

-$1.90M

Repayment of Debt (TTM)

-$1.90M

Key Statistics

Open

$4.19

$4.40

Volume / Avg.

23.97K / 164.80K

Day Range

$4.16 - $4.40

52 Wk Range

3.50 - 16.25

Market Cap

$32.09M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.51%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry